SRRK has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
SRRK has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Scholar Rock Holding's yield on cost for the quarter that ended in Dec. 2024 was 0.00.
The historical rank and industry rank for Scholar Rock Holding's 5-Year Yield-on-Cost % or its related term are showing as below:
For the Biotechnology subindustry, Scholar Rock Holding's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Biotechnology industry and Healthcare sector, Scholar Rock Holding's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Scholar Rock Holding's 5-Year Yield-on-Cost % falls into.
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Therefore, Yield-on-Cost of Scholar Rock Holding is calculated as
Yield-on-Cost | = | Dividend Yield % | * | (1 | + | Dividend Growth Rate)^5 |
Scholar Rock Holding (NAS:SRRK) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Thank you for viewing the detailed overview of Scholar Rock Holding's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.
Edward H Myles | director | C/O AMAG PHARMACEUTICALS, INC., 1100 WINTER STREET, WALTHAM MA 02451 |
Mo Qatanani | officer: SVP and Head of Research | 301 BINNEY STREET, 3RD FLOOR, C/O SCHOLAR ROCK HOLDING CORP, CAMBRIDGE MA 02142 |
Caryn Parlavecchio | officer: CHRO | SCHOLAR ROCK HOLDING CORPORATION, 301 BINNEY STREET, 3RD FLOOR, CAMBRIDGE MA 02142 |
Junlin Ho | officer: General Counsel | 301 BINNEY STREET, CAMBRIDGE MA 02142 |
Jay T. Backstrom | officer: CEO-Elect | SCHOLAR ROCK HOLDING CORPORATION, 301 BINNEY STREET, 3RD FLOOR, CAMBRIDGE MA 02142 |
Tracey Sacco | officer: Chief Commercial Officer | 301 BINNEY STREET, 3RD FLOOR, C/O SCHOLAR ROCK HOLDING CORP, CAMBRIDGE MA 02142 |
Jing L. Marantz | officer: Chief Medical Officer | C/O KRYSTAL BIOTECH, INC., 2100 WHARTON STREET, SUITE 701, PITTSBURGH PA 15203 |
Invus Public Equities, L.p. | 10 percent owner | C/O THE INVUS GROUP, LLC, 750 LEXINGTON AVENUE, 30TH FLOOR, NEW YORK NY 10022 |
Srinivas Akkaraju | director | 565 EVERETT AVENUE, PALO ALTO CA 94301 |
Samsara Biocapital Gp, Llc | 10 percent owner | 251 CHURCHILL AVENUE, PALO ALTO CA 94301 |
Richard Brudnick | director | BIOVERATIV INC., 225 SECOND AVENUE, WALTHAM MA 02451 |
Amir Nashat | director | 10835 ROAD TO THE CURE, SUITE 205, SAN DIEGO CA 92121 |
Samsara Biocapital, L.p. | 10 percent owner | 628 MIDDLEFIELD ROAD, PALO ALTO CA 94301 |
Amaury Wittouck | 10 percent owner | VALLEY PARK, 44, RUE DE LA VALLEE, LUXEMBOURG N4 L2661 |
Artal Group S.a. | 10 percent owner | VALLEY PARK, 44, RUE DE LA VALLEE, LUXEMBOURG N4 L-2661 |
From GuruFocus
By GuruFocus News • 02-26-2025
By GuruFocus News • 01-02-2025
By Business Wire • 01-02-2025
By GuruFocus News • 01-29-2025
By Business Wire • 01-29-2025
By Business Wire • 02-14-2025
By GuruFocus News • 02-15-2025
By Business Wire • 02-10-2025
By GuruFocus News • 02-27-2025
By GuruFocus News • 02-25-2025
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.